Elective Stenting of Symptomatic Middle Cerebral Artery Stenosis
AJNR 21:971-973, Gomez,C.R.,et al, 2000
Decreasing Incidence of CNS AIDS-Defining Events Associated with Antiretroviral Therapy
Neurol 54:1856-1859, d'Arminion Monforte,A.,et al, 2000
Axial Parkinsonian Symptoms Can Be Improved: The Role of Levodopa and Bilateral Subthalamic Stimulation
JNNP 68:595-600, Bejjani,B.P.,et al, 2000
Hyponatremia, Cerebral Edema, and Noncardiogenic Pulmonary Edema in Marathon Runners
Ann Int Med 132:711-714, Ayus,J.C.,et al, 2000
Radiotherapy for Graves' Orbitopathy: Randomised Placebo-Controlled Study
Lancet 355:1505-1509, Mourits,M.P.,et al, 2000
Treatment of Acromegaly With the Growth Hormone-Receptor Antagonist Pegvisomant
NEJM 342:1171-1177,1210, Trainer,P.J.,et al, 2000
Long-Term Outcome of Low-Grade Oligodendroglioma and Mixed Glioma
Neurol 54:1442-1448,1402, Olson,J.D.,et al, 2000
Quetiapine for L-Dopa-Induced Psychosis in PD
Neurol 54:1538, Weiner,W.J.,et al, 2000
A Five-Year Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease who were Treated with Ropinirole or Levodopa
NEJM 342:1484-1491, Rascol,O.,et al, 2000
Treating Hyperhidrosis
BMJ 320:1221-1222, Collin,J.&Whatling,P., 2000
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000
Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000
Oral Zolmitriptan is Effective in the Acute Treatment of Cluster Headache
Neurol 54:1832-1839, Bahra,A.,et al, 2000
Secondary Prevention of Transient Ischaemic Attack and Stroke
BMJ 320:991-994, Lees,K.R.,et al, 2000
Helicobacter pylori -- Is It a Novel Causative Agent in Vitamin B12 Deficiency?
Arch Int Med 160:1349-1353,1229, Kaptan,K.,et al, 2000
Treatment of Ocular Myasthenia
Arch Neurol 57:752-753, Kaminski,H.J.&Daroff,R.B., 2000
Treatment of Ocular Myasthenia With Corticosteroids
Arch Neurol 57:750-751,753, Agius,M.A., 2000
Dermatomyositis
Lancet 355:53-57, Callen,J.P., 2000
Selective Infusion of Urokinase and Thrombectomy in the Treatment of Acute Cerebral Sinus Thrombosis
AJNR 21:143-145, Novak,Z.,et al, 2000
Superior Sagittal Sinus Thrombosis Due to Lithium:Local Urokinase Thrombolysis Treatment
Neurol 54:532-533, Wasay,M.,et al, 2000
Carotid Endarterectomy, A Neurotherapeutic Advance
Arch Neurol 57:40-45, Barnett,H.J.M.&Meldrum,H.E., 2000
Ischemia After Carotid Endarterectomy:Comparison between Transcranial Doppler Sonography and Diffusion-Weighted MR Imaging
AJNR 21:47-54,41, Muller,M.,et al, 2000
Antifibrinolytic Treatment in Subarachnoid Hemorrhage, A Randomized Placebo-Controlled Trial
Neurol 54:77-82, Roos,Y.,STAR Study Group, 2000
Effect of Hypervolemic Therapy on Cerebral Blood Flow After Subarachnoid Hemorrhage, A Randomized Controlled Trial
Stroke 31:383-391, Lennihan,L.,et al, 2000
AGGRENOX: A Combination of Antiplatelet Drugs for Stroke Prevention
The Medical Letter 442:11-12, , 2000
Effect of Endovascular Services and Hospital Volume on Cerebral Aneurysm Treatment Outcomes
Stroke 31:111-117, Johnston,S.C., 2000
rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000
Elective Stenting of Symptomatic Basilar Artery Stenosis
Stroke 31:95-99, Gomez,C.R.,et al, 2000
Most Commonly Asked Questions About Carotid Angioplasty and Stenting
The Neurologist 6:58-61, Cates,C.U., 2000
Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000
Identification of Patients at Risk for Periprocedural Neurological Deficits Associated with Carotid Angioplasty and Stenting
Stroke 31:376-382, Qureshi,A.I.,et al, 2000
Effect of Interferon B-1b in MS, Assessment of Annual Accumulation of PD/T2 Activity on MRI
Neurol 54:200-206, Zhao,G.J.,et al, 2000
Donepezil Therapy in Clinical Practice, A Randomized Crossover Study
Arch Neurol 57:94-99, Greenberg,S.M.,et al, 2000
Intraspinal Hemorrhage Complicating Oral Anticoagulant Therapy, An Unusual Case of Cervical Hematomyelia and a Review of the Literature
Arch Int Med 160:237-240, Pullarkat,V.A.,et al, 2000
Pharmacologic Paralysis and Withdrawal of Mechanical Ventilation at the End of Life
NEJM 342:508-511, Truog,R.D.,et al, 2000
Rethinking the Role of Tube Feeding in Patients with Advanced Dementia
NEJM 342:206-210, Gillick,M.R., 2000
Remission of HIV Myelopathy After Highly Active Antiretroviral Therapy
Neurol 54:267-268, Staudinger,R.&Henry,K., 2000
Estrogen for Alzheimer's Disease in Women, Randomized, Double-Blind, Placebo-Controlled Trial
Neurol 54:295-301, Henderson,V.W.,et al, 2000
Endovascular Treatment of Ruptured Posterior Circulation Cerebral Aneurysms, Clinical and Angiographic Outcomes
Stroke 31:100-110, Lempert,T.E.,et al, 2000
Neurogene Therapy for the 21st Century
Arch Neurol 57:54, Brady,R.O., 2000
Eletriptan in Acute Migraine:A Double-Blind,Placebo-Controlled Comparison to Sumatriptan
Neurol 54:156-163, Goadsby,P.J.,et al, 2000
A Randomized Trial of 3,4-Diaminopyridine in Lambert-Eaton Myasthenic Syndrome
Neurol 54:603-607, Sanders,D.B.,et al, 2000
Objective Changes in Motor Function During Placebo Treatment in PD
Neurol 54:710-714, Goetz,C.G.,et al, 2000
Effects of Bilateral Posteroventral Pallidotomy on Gait of Subjects with Parkinson Disease
Arch Neurol 57:198-204, Siegel,K.L.&Metman,L.V., 2000
Tolcapone and Hepatotoxic Effects
Arch Neurol 57:263-267, Olanow,C.W.&Tasmar Advisory Panel, 2000
When Does the Patient with a Disc Herniation Undergo Lumbosacral Discectomy?
JNNP 68:75-79, Vroomen,P.C.A.J.,et al, 2000
New Drugs:Which Should Be Included in the Formulary?, Epilepsy:All New Drugs Should Be Included
Arch Neurol 57:272-273,275, Pierre-Louis,S.J.C., 2000